| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $91.2M | +23.5% |
| Cost of Revenue | $76.9M | +18.7% |
| Gross Profit | $14.3M | +57.6% |
| R&D Expense | $2.5M | +3.7% |
| SG&A Expense | $32.2M | +27.9% |
| Operating Income | -$20.4M | -10.3% |
| Pre-tax Income | $7.4M | +130.2% |
| Income Tax | $14K | +100.0% |
| Net Income | $7.4M |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $6.6M | -7.7% |
| Inventory | $20.6M | -44.7% |
| Current Assets | $34.7M | -46.3% |
| Total Assets | $84.2M | -22.1% |
| Current Liabilities | $73.2M | -39.8% |
| Long-term Debt | $28.9M | — |
| Total Liabilities | $85.0M | -35.7% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$27.7M | -248.2% |
| Capital Expenditures | $4.7M | -43.2% |
| Investing Cash Flow | -$4.7M | +43.2% |
| Financing Cash Flow | $21.6M | +234.8% |
| Free Cash Flow | -$32.3M | -100.0% |
| +130.1% |
| EPS (Basic) | $0.39 | +127.3% |
| EPS (Diluted) | $0.39 | +127.3% |
| Stockholders' Equity |
| -$14.6M |
| +39.2% |